ConductScience.org, home

Gene · 3978

Papers1,551

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

341 to 360 of 1,551

Download this page as JSON
TitleJournalYearPMIDFound bySource
Trovafloxacin drives inflammation-associated drug-induced adverse hepatic reaction by changing macrophage polarization.Toxicol In Vitro202235537566PubTator, text miningPubMed
Role of EMT in the DNA damage response, double-strand break repair pathway choice and its implications in cancer treatment.Cancer Sci202235534984PubTator, text miningPubMed
Decoding the pathogenesis of Diamond-Blackfan anemia using single-cell RNA-seq.Cell Discov202235534476PubTator, text miningPubMed
Heterogeneous genetic landscape of congenital neutropenia in Korean patients revealed by whole exome sequencing: genetic, phenotypic and histologic correlations.Sci Rep202235525891PubTator, text miningPubMed
DNA repair and damage pathways in mesothelioma development and therapy.Cancer Cell Int202235501851PubTator, text miningPubMed
Structure-specific nucleases: role in Okazaki fragment maturation.Trends Genet202235491358PubTator, text miningPubMed
Breakage of cytoplasmic chromosomes by pathological DNA base excision repair.Nature202235477155PubTator, text miningPubMed
Motif-centric phosphoproteomics to target kinase-mediated signaling pathways.Cell Rep Methods202235474870PubTator, text miningPubMed
Luteolin impacts deoxyribonucleic acid repair by modulating the mitogen-activated protein kinase pathway in colorectal cancer.Bioengineered202235473479PubTator, text miningPubMed
PRKDC promotes hepatitis B virus transcription through enhancing the binding of RNA Pol II to cccDNA.Cell Death Dis202235468873PubTator, text miningPubMed
Impact of DNA damage response defects in cancer cells on response to immunotherapy and radiotherapy.J Med Imaging Radiat Oncol202235460184PubTator, text miningPubMed
Nanoconjugate Synthesis of Elaeocarpus ganitrus and the Assessment of Its Antimicrobial and Antiproliferative Properties.Molecules202235458641PubTator, text miningPubMed
Development and Evolution of DNA-Dependent Protein Kinase Inhibitors toward Cancer Therapy.Int J Mol Sci202235457081PubTator, text miningPubMed
Genome Integrity and Neurological Disease.Int J Mol Sci202235456958PubTator, text miningPubMed
Polyglutamine Expansion in Huntingtin and Mechanism of DNA Damage Repair Defects in Huntington's Disease.Front Cell Neurosci202235444517PubTator, text miningPubMed
A Whole-Genome CRISPR Screen Identifies AHR Loss as a Mechanism of Resistance to a PARP7 Inhibitor.Mol Cancer Ther202235439318PubTator, text miningPubMed
Immune-Related lncRNAs Pairs to Construct a Novel Signature for Predicting Prognosis in Gastric Cancer.Front Surg202235402492PubTator, text miningPubMed
Integrative proteomic characterization of trace FFPE samples in early-stage gastrointestinal cancer.Proteome Sci202235397555PubTator, text miningPubMed
Identification of Significant Genes and Pathways Associated with Tenascin-C in Cancer Progression by Bioinformatics Analysis.Adv Biomed Res202235386538PubTator, text miningPubMed
Exome sequencing of individuals with Huntington's disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset.Nat Neurosci202235379994PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3978/papers?page=18